Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

The epidemiology of NSAID gastropathy: the ARAMIS experience.

Fries JF.

J Clin Rheumatol. 1998 Oct;4(5 Suppl):s11-6.

PMID:
19078320
2.

Kinetic basis for selective inhibition of cyclo-oxygenases.

Gierse JK, Koboldt CM, Walker MC, Seibert K, Isakson PC.

Biochem J. 1999 May 1;339 ( Pt 3):607-14.

3.
4.

COX-2 inhibitors.

Hawkey CJ.

Lancet. 1999 Jan 23;353(9149):307-14.

PMID:
9929039
5.
6.

Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment.

Hawkey C, Kahan A, Steinbrück K, Alegre C, Baumelou E, Bégaud B, Dequeker J, Isomäki H, Littlejohn G, Mau J, Papazoglou S.

Br J Rheumatol. 1998 Sep;37(9):937-45. Erratum in: Br J Rheumatol 1998 Oct;37(10):1142.

7.

Cyclooxygenases 1 and 2.

Vane JR, Bakhle YS, Botting RM.

Annu Rev Pharmacol Toxicol. 1998;38:97-120. Review.

PMID:
9597150
8.

Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs.

Patrignani P, Panara MR, Sciulli MG, Santini G, Renda G, Patrono C.

J Physiol Pharmacol. 1997 Dec;48(4):623-31.

PMID:
9444611
9.
10.

Clinical pharmacokinetics of diclofenac. Therapeutic insights and pitfalls.

Davies NM, Anderson KE.

Clin Pharmacokinet. 1997 Sep;33(3):184-213. Review.

PMID:
9314611
11.

Clinical pharmacokinetics of sulindac. A dynamic old drug.

Davies NM, Watson MS.

Clin Pharmacokinet. 1997 Jun;32(6):437-59. Review.

PMID:
9195115
12.
13.

Clinical pharmacokinetics of naproxen.

Davies NM, Anderson KE.

Clin Pharmacokinet. 1997 Apr;32(4):268-93. Review.

PMID:
9113437
14.

A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors.

Brideau C, Kargman S, Liu S, Dallob AL, Ehrich EW, Rodger IW, Chan CC.

Inflamm Res. 1996 Feb;45(2):68-74.

PMID:
8907587
15.

Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

Reuter BK, Asfaha S, Buret A, Sharkey KA, Wallace JL.

J Clin Invest. 1996 Nov 1;98(9):2076-85.

16.

Meloxicam.

Noble S, Balfour JA.

Drugs. 1996 Mar;51(3):424-30; discussion 431-32. Review.

PMID:
8882380
17.
18.

Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis.

Henry D, Lim LL, Garcia Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT.

BMJ. 1996 Jun 22;312(7046):1563-6.

19.
20.

Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR.

Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11693-7.

Items per page

Supplemental Content

Write to the Help Desk